Back to Network
3
Shared Docs
3
Same-Page
3 / 3
Mentions
Document Mentions (3 shared documents)
2 mentions1 same-page
Page ?Same page
er and Senior Vice President of medical affairs at Cell Genesys. He oversaw all clinical, regulatory and medical affairs activities associated with Cell Genesys' product portfolio. Prior to Cell Genesys, he was Chief Executive Officer of Biolitec Pharma Ltd., a U.K.-based biotechnology company, and also prev
regulatory and medical affairs activities associated with Cell Genesys' product portfolio. Prior to Cell Genesys, he was Chief Executive Officer of Biolitec Pharma Ltd., a U.K.-based biotechnology company, and also previously held senior executive positions with Quantanova and Scotia Holdings, plc. Prior to that, D
2 mentions1 same-page
Page ?Same page
er and Senior Vice President of medical affairs at Cell Genesys. He oversaw all clinical, regulatory and medical affairs activities associated with Cell Genesys' product portfolio. Prior to Cell Genesys, he was Chief Executive Officer of Biolitec Pharma Ltd., a U.K.-based biotechnology company, and also prev
regulatory and medical affairs activities associated with Cell Genesys' product portfolio. Prior to Cell Genesys, he was Chief Executive Officer of Biolitec Pharma Ltd., a U.K.-based biotechnology company, and also previously held senior executive positions with Quantanova and Scotia Holdings, plc. Prior to that, D
2 mentions1 same-page
Page ?Same page
er and Senior Vice President of medical affairs at Cell Genesys. He oversaw all clinical, regulatory and medical affairs activities associated with Cell Genesys' product portfolio. Prior to Cell Genesys, he was Chief Executive Officer of Biolitec Pharma Ltd., a U.K.-based biotechnology company, and also prev
regulatory and medical affairs activities associated with Cell Genesys' product portfolio. Prior to Cell Genesys, he was Chief Executive Officer of Biolitec Pharma Ltd., a U.K.-based biotechnology company, and also previously held senior executive positions with Quantanova and Scotia Holdings, plc. Prior to that, D
Sponsored
Mutual Connections (64)
Entities connected to both Cell Genesys' and Biolitec Pharma Ltd.
SH
Shenk
PERSON3 w/ Cell·3 w/ Biolitec
Kansas
LOCATION3 w/ Cell·3 w/ Biolitec
Target
ORGANIZATION3 w/ Cell·3 w/ Biolitec
Basel
ORGANIZATION3 w/ Cell·3 w/ Biolitec
Elkins
PERSON3 w/ Cell·3 w/ Biolitec
American Cancer Society Professorship
ORGANIZATION3 w/ Cell·3 w/ Biolitec
Investigatorship
ORGANIZATION3 w/ Cell·3 w/ Biolitec
Biosecurity
ORGANIZATION3 w/ Cell·3 w/ Biolitec
Strategic Product Development
ORGANIZATION3 w/ Cell·3 w/ Biolitec
Quantanova
ORGANIZATION3 w/ Cell·3 w/ Biolitec
the University of St. Andrews
ORGANIZATION3 w/ Cell·3 w/ Biolitec
the Faculty of Pharmaceutical Physicians
ORGANIZATION3 w/ Cell·3 w/ Biolitec
Cobalt Technologies, Inc.
ORGANIZATION3 w/ Cell·3 w/ Biolitec
Xenogen Corporation
ORGANIZATION3 w/ Cell·3 w/ Biolitec
Microbiology and Engineering
ORGANIZATION3 w/ Cell·3 w/ Biolitec
Medarex, Inc.
ORGANIZATION3 w/ Cell·3 w/ Biolitec
Bristol Myers Squibb Company
ORGANIZATION3 w/ Cell·3 w/ Biolitec
GlaxoSmithKline plc
ORGANIZATION3 w/ Cell·3 w/ Biolitec
International Pharmaceuticals
ORGANIZATION3 w/ Cell·3 w/ Biolitec
SmithKline Beecham plc
ORGANIZATION3 w/ Cell·3 w/ Biolitec